Abstract

The excellent publication by Häusler and Weber [...].

Highlights

  • Vitamin D Supplementation as Add-on Therapy in Multiple Sclerosis—Balance between Benefit and Risk?: A Commentary on Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough

  • Because vitamin D (VD) intoxication without hypervitaminosis has been verified in anecdotal reports, calcium excretion can be determined by a 24 h urine collection as an option for confirmation [6]

  • At a weekly dose of 20,000 IU VD in people with multiple sclerosis (PwMS) and disease-modifying drugs (DMD), Holmoy et al did not achieve an overall effect on sNFL levels, but in a subgroup of patients not receiving DMD, sNFL decreased more than 30% [19]

Read more

Summary

Introduction

Vitamin D Supplementation as Add-on Therapy in Multiple Sclerosis—Balance between Benefit and Risk?: A Commentary on Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough. A moderate add-on therapy with vitamin D (VD) doses of up to 10,000 IU/day hardly presents a risk of hypercalcemia [3]. It is known that VD increases the absorption of calcium from the intestines, this effect is generally subject to physiological regulation.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.